
FIB-4 followed by VCTE or ELF ruled out advanced fibrosis in most people with type 2 diabetes or complicated obesity in modeled primary care data.

Zobair Younossi, MD, MPH, is chairman of the Global NASH/MASH Council and professor and chairman of Beatty Liver and Obesity Research at Inova Health System.